Tolerability of voriconazole and nebulised liposomal amphotericin in the treatment of allergic bronchopulmonary aspergillosis (ABPA) in children with CF

被引：0
|
作者：
Thomas, B. [1 ]
Chilvers, M. [1 ]
Adamson, S. [1 ]
Claydon, A. [1 ]
O'Callaghan, C. [1 ]
机构：
[1] Childrens Hosp, Leicester Royal Infirm, Leicester, Leics, England
来源：
PEDIATRIC PULMONOLOGY | 2007年
关键词：
D O I：
暂无
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
391
引用
收藏
页码：341 / 342
页数：2
相关论文
共 50 条
  • [1] Nebulised amphotericin in allergic bronchopulmonary aspergillosis (ABPA) and severe asthma with fungal sensitization (SAFS)
    Chishimba, L.
    Niven, M.
    Powell, L.
    Denning, W.
    Langridge, J.
    MYCOSES, 2013, 56 : 163 - 163
  • [2] NEBULISED AMPHOTERICIN IN ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS (ABPA) AND SEVERE ASTHMA WITH FUNGAL SENSITISATION (SAFS)
    Chishimba, L.
    Langridge, P.
    Powell, G.
    Denning, D. W.
    Niven, R.
    THORAX, 2013, 68 : A49 - A50
  • [3] ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS (ABPA) IN CHILDREN
    LERNER, CJ
    GEWURZ, A
    GREENBERGER, P
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1985, 75 (01) : 133 - 133
  • [4] Omalizumab for the treatment of allergic bronchopulmonary aspergillosis (ABPA) in children "th cystic fibrosis (CF)
    Gartner, Silvia
    Rovira, Sandra
    de Mir, Ines
    Torrent, Alba
    Caurin, Belen
    Sacoto, Gabriela
    Canino, Elisa
    Moreno-Galdo, Antonio
    EUROPEAN RESPIRATORY JOURNAL, 2014, 44
  • [5] Nebulised liposomal amphotericin-B as maintenance therapy in allergic bronchopulmonary aspergillosis: a randomised, multicentre trial
    Godet, Cendrine
    Couturaud, Francis
    Marchand-Adam, Sylvain
    Pison, Christophe
    Gagnadoux, Frederic
    Blanchard, Elodie
    Taille, Camille
    Philippe, Bruno
    Hirschi, Sandrine
    Andrejak, Claire
    Bourdin, Arnaud
    Chenivesse, Cecile
    Dominique, Stephane
    Bassinet, Laurence
    Murris-Espin, Marlene
    Riviere, Frederic
    Garcia, Gilles
    Caillaud, Denis
    Blanc, Francois-Xavier
    Goupil, Francois
    Bergeron, Anne
    Gondouin, Anne
    Frat, Jean-Pierre
    Flament, Thomas
    Camara, Boubou
    Priou, Pascaline
    Brun, Anne-Laure
    Laurent, Francois
    Ragot, Stephanie
    Cadranel, Jacques
    EUROPEAN RESPIRATORY JOURNAL, 2022, 59 (06)
  • [6] Allergic bronchopulmonary aspergillosis (ABPA) and omalizumab treatment
    Mur Gimeno, P.
    Sanchez Bommatty, M.
    Gil Munoz, F. L.
    Roa Llamazares, C.
    Palomar Estrada, A.
    ALLERGY, 2019, 74 : 457 - 457
  • [7] Omalizumab for the treatment of allergic bronchopulmonary aspergillosis (ABPA).
    Hsu, R. T.
    Klaustermeyer, W. B.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2007, 98 (01) : A36 - A36
  • [8] Allergic Bronchopulmonary Aspergillosis (ABPA)
    Cohen-Cymberknoh, Malena
    PEDIATRIC PULMONOLOGY, 2017, 52 : S64 - S65
  • [9] Efficacy and safety of nebulised amphotericin B (NAB) in severe asthma with fungal sensitisation (SAFS) and allergic bronchopulmonary aspergillosis (ABPA)
    Chishimba, Livingstone
    Langridge, Philip
    Powell, Georgina
    Niven, Robert M.
    Denning, David W.
    JOURNAL OF ASTHMA, 2015, 52 (03) : 289 - 295
  • [10] Allergic bronchopulmonary aspergillosis (ABPA)
    Menz, G
    Crameri, R
    Hense, G
    ALLERGOLOGIE, 2005, 28 (08) : 315 - +
12345